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The emergent Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) could produce a maternal immune
activation (MIA) via the inflammatory response during gestation that may impair fetal
neurodevelopment and lead to postnatal and adulthood mental illness and behavioral
dysfunctions. However, so far, limited evidence exists regarding long-term physiological,
immunological, and neurodevelopmental modifications produced by the SARS-CoV-2 in
the human maternal-fetal binomial and, particularly, in the offspring. Relevant findings
derived from epidemiological and preclinical models show that a MIA is indeed linked
to an increased risk of neurodevelopmental disorders in the offspring. We hypothesize
that a gestational infection triggered by SARS-CoV-2 increases the risks leading to
neurodevelopmental disorders of the newborn, which can affect childhood and the
long-term quality of life. In particular, disruption of either the maternal or the fetal
cholinergic anti-inflammatory pathway (CAP) could cause or exacerbate the severity of
COVID-19 in the maternal-fetal binomial. From a translational perspective, in this paper,
we discuss the possible manifestation of a MIA by SARS-CoV-2 and the subsequent
neurodevelopmental disorders considering the role of the fetal-maternal cytokine
cross-talk and the CAP. Specifically, we highlight the urgent need of preclinical studies
as well as multicenter and international databanks of maternal-fetal psychophysiological
data obtained pre-, during, and post-infection by SARS-CoV-2 from pregnant women
and their offspring.
Keywords: cholinergic anti-inflammatory pathway, quality of life, COVID-19, neurodevelopmental disorders,
human development, heart rate variability, SARS-CoV-2, maternal immune activation
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INTRODUCTION
During pregnancy, there is an increased risk of infection
by viruses and bacteria (Silasi et al., 2015; Barinov et al.,
2020). Throughout this unique physiological condition, pregnant
women are susceptible to gestational infections owing to
immunomodulatory changes that naturally occur in their bodies,
allowing the implantation and growth of the fetal allograft
(Hedge, 1991). Pregnancy was early considered as a high-
risk condition for contracting the COVID-19 disease (Phoswa
and Khaliq, 2020); approximately 200 million pregnant women
were estimated as having a potential risk of SARS-CoV-2
infection worldwide (Vogel, 2020). It could be presumed that the
gestational period makes difficult the clinical course of COVID-
19 and thus become related with an increased mortality rate.
Cardinal clinical manifestations of patients with COVID-19
disease include fever, cough, and dyspnea (Harapan et al., 2020;
Knight et al., 2020; Rodriguez-Morales et al., 2020). Among these
patients, the most significant comorbidities are hypertension,
cardiovascular disease, and diabetes (Rodriguez-Morales et al.,
2020). In pregnant women, recent evidence has shown that the
occurrence of COVID-19 during gestation is mainly associated
with higher preterm birth rates (Allotey et al., 2020). Yet, an
increased number of intrauterine fetal and neonatal deaths,
premature rupture of membranes, and miscarriages as well as a
reduction of fetal movements have also been documented in a
systematic review (Amaral et al., 2020).
The COVID-19 pandemic has forced to establish priority in
the short-term mitigating health systems mechanisms. However,
owing to the pandemic recent upsurge, no evidence has been
reported concerning the middle- and long-term neuroimmune
perinatal alterations. Specifically, the effects caused by this
disease in vulnerable groups, such as pregnant women and
their offspring. Some authors have already proposed that this
disease could alter fetal neurodevelopment and even postnatal
life (Liu H. et al., 2020). With this perspective article, we first
describe the principle of a potential maternal immune activation
(MIA) by SARS-CoV-2, as well as the maternal response and
inflammation occurred in response to this severe infection. Next,
we consider the possibility of neurodevelopmental disorders of
the offspring in response to a COVID-19 disease. Additionally,
we introduce a possible relationship between the cholinergic
anti-inflammatory pathway (CAP), a complex neuroimmune
mechanism (Huston and Tracey, 2011), and COVID-19 in
pregnancy. Finally, we discuss some autonomic measures, such
as those derived from the analysis of maternal and fetal
heart rate variability (HRV), which may contribute to our
current understanding of COVID-19 in a perinatal translational
research. The hypothesized associations among SARS-CoV-2,
MIA, the CAP, and neurodevelopmental disorders are shown in
Figure 1.
Some specific examples and evidence concerning MIA,
CAP, and neurodevelopmental disorders are presented in
the following subsections, whereas our final hypothesis and
opinions linking these topics are mainly addressed in the
perspective section.
MIA AND SARS-CoV-2
Infections during pregnancy can cause disturbances in fetal
neurodevelopment by the elevation of pro-inflammatory
cytokines in the maternal host. Interleukin 6 (IL-6) has
been described as a key molecular mediator for the
early pathophysiological mechanisms that predispose to
neuropsychiatric disorders such as schizophrenia and autism
(Smith et al., 2007). Actually, a link between influenza outbreaks
and increased risks for schizophrenia in the offspring has
been already reported (Tochigi et al., 2004). In a mouse model
of influenza infection in pregnancy, an upregulation of the
serotonin 5-HT2A receptor in the offspring cortex is observed,
which is similarly reported in the postmortem prefrontal cortex
from schizophrenic patients (Saunders et al., 2020). In other
preclinical models of MIA, the activation of the innate immunity
of a pregnant female mouse is mediated by the Toll-like receptor
3 (TLR-3) pathway through the use of a synthetic immunogen,
poly-inosinic acid: poly-cytidylic (Poly I:C), which is a mimetic
molecule of the replicating genome of single-stranded RNA
viruses. This molecular pattern of a double strand of RNA is
recognized by the TLR-3 of host innate immune cells, inducing
the activation of the transcriptional factor NF-κB that promotes
the expression of inflammatory cytokines and the production
of type 1 interferons (Alexopoulou et al., 2001). Similarly,
several infections of other single-stranded RNA genome viruses
such as SARS-CoV and the Middle East Respiratory Syndrome
Coronavirus (MERS-CoV) have also been found to activate TLR
pathways, specifically that of the TLR-3, generating aberrant
signaling through inflammatory cytokines, chemokines, and
interferons (Totura et al., 2015).
It has been consistently documented that the infection by
SARS-CoV-2 generates a complex production of molecules of
the inflammatory response. For example, increased levels of
cytokines (IL-6, IL-10, and TNF-α), lymphopenia in T cells
(CD4 + and CD8 +), and a decreased expression of IFN-γ
in CD4 + T cells have all been reported (Pedersen and Ho,
2020). These immunological changes are even associated with
the severity of COVID-19 disease (Pedersen and Ho, 2020).
Similarly, some patients with SARS-CoV-2 have shown a TH17
cytokine profile, contributing to the cytokine storm syndrome
(CSS) (Ur and Verma, 2020; Ye et al., 2020). Notwithstanding
that several cytokines are involved in such TH17 cell response,
the most relevant is the surge of IL-17 that is responsible
for granulopoiesis and neutrophil recruitment (Wu and Yang,
2020). This evidence suggests that patients with severe COVID-
19 manifest an uncontrolled excessive inflammatory response,
characterized by a hyperinflammatory response to SARS-CoV-
2 that is facilitated by a possible unregulated immune system
of the host. At present, few clinical studies have been carried
out to explore the manifestation and the effects of CSS by
COVID-19 during human pregnancy. Nonetheless, some case
studies showing respiratory diseases, abnormal Apgar indexes,
and pneumonia have already been reported in neonates born
from SARS-CoV-2-infected women (Nayak et al., 2020; Wu et al.,
2020).
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FIGURE 1 | A gestational infection triggered by SARS-CoV-2 may produce a maternal immune activation (MIA) and cytokine storm syndrome (CSS). The activation of
the maternal and/or fetal cholinergic anti-inflammatory pathway (CAP) via the efferent vagus nerve and transplacental interactions could downregulate such CSS. The
analysis of maternal and fetal heart rate variability (mHRV and fHRV) might be considered for assessing maternal and fetal CAP activation. Also, a gestational infection
by SARS-CoV-2 may produce fetal neuroinflammation and microglial activation, increasing the risks of several neurodevelopmental disorders in the offspring and even
an altered long-term cognitive function in adulthood: (1) neuronal migration; (2) axonal and dendritic growth; (3) programmed cell death; (4) synaptogenesis; (5)
myelination; and (6) process modeling/synaptic refinement. ASD, autism spectrum disorder; SCZ, schizophrenia; AD, anxiety disorders; MD, mood disorders; ICD,
impulse-control disorders.
Furthermore, relevant evidence documented that the
transplacental transmission of SARS-CoV-2 infection is possible
during the last weeks of pregnancy (Vivanti et al., 2020). Recent
pathology findings in placentas of SARS-CoV-2-infected cases
show mononuclear cell inflammation of the intervillous space,
which is accompanied by a syncytiotrophoblast necrosis
(Schwartz and Morotti, 2020). In addition to placental
inflammation and neonatal viremia, the transfer of pro-
inflammatory cytokines across the placenta could lead to fetal
brain cortical malformations, and changes in macrophages
function that may be even sustained up to adulthood in
accordance with the so-called “Barker hypothesis of the fetal
origin of adult disease” (Barker, 2001). Novel preclinical
findings indicate that MIA alters fetal brain development,
with implications for long-term cognitive function and




Findings derived from epidemiological and preclinical models
also show that MIA caused by a viral infection might be linked
to an increased risk of neurodevelopmental disorders in the
offspring, such as the autism spectrum disorder, schizophrenia,
and depression (Pacheco-López et al., 2013; Meyer, 2014; Al-
Haddad et al., 2019). Recent studies have even postulated that
the dietary intake of anti-inflammatory nutrition in pregnant
women with COVID-19 infection and their children could help
reduce the risk of neuropsychiatric disorders (Hashimoto, 2020).
Other evidence indicates that a severe crisis or traumatic situation
in childhood may lead to difficulties in psychological regulation
(Thabrew et al., 2012) and increase the risk of diseases during
adult life (Vargas, 2012). In the antenatal and early childhood
stages, these episodes can cause adverse effects to the subjects,
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who are supposed to live in a stable and protective environment
(López Soler, 2008). Therefore, an irruption of the life cycle at any
of such stages may generate long-term repercussions in different
areas of human development, its capacities, and corresponding
quality of life (United Nations Development Programme, 2014).
Some studies show that critical or stressful situations during
pregnancy generate posterior difficulties in childhood. For
example, external environmental factors such as domestic
violence, other crises, and psychological trauma affect pregnancy
outcomes (López Soler, 2008; Vargas, 2012). COVID-19 should
thus act as a complex insult for pregnant women. In fact, knowing
a positive diagnostic test result of COVID-19 may generate
important physical and emotional implications in pregnant
women who may become anxious in identifying themselves as
sick people at risk (Bermejo-Sánchez et al., 2020; Lorenzo Ruiz
et al., 2020). Different studies have shown that the presence of a
variety of psychiatric disorders in adulthood has been associated
with early traumatic experiences (Ordóñez-Camblor et al., 2016).
Events in early life and childhood alter the neurodevelopment,
the dynamic gene-environment interplay, and the programming
of the body’s neurological, immune, and endocrine systems
(National Research Council (US) Institute of Medicine (US)
Committee on Integrating the Science of Early Childhood
Development, 2000). We consider that this neuro-immune-
endocrine insult, as COVID-19, has long-lasting implications for
subsequent trajectories of human development (United Nations
Development Programme, 2014).
Pregnant women with confirmed COVID-19 infection should
be closely supervised and monitored to be able to early recognize
any clinical deterioration of the mother and fetus. In this context,
we propose, as one possible approach to facilitate this follow-up,
to monitor both maternal and fetal neuro-immune interactions
by assessing the CAP (Gallowitsch-Puerta and Pavlov, 2007).
THE CAP AND COVID-19
Our knowledge about the neuroimmune changes that exists in
the maternal-fetal binomial owing to a COVID-19 infection
is minimal; however, some homeostatic mechanisms such the
maternal or fetal CAP could be crucial or become altered during
pregnancy. The CAP is a complex neuroimmune homeostatic
mechanism that suppresses pro-inflammatory cytokine release
via the vagus nerve (Huston and Tracey, 2011; Ur and Verma,
2020). The nucleus tractus solitarii integrates the CAP with other
immunomodulatory responses because it spreads afferent vagal
nerve neuroimmunomodulation signals to the brain (Pavlov
et al., 2003). Specifically, an inflammation of the nucleus tractus
solitarii can cause a disruption of the CAP and the hypothalamic–
pituitary–adrenal axis resulting in a CSS (Ur and Verma, 2020).
In pregnant women, we hypothesize that the activation of
the maternal and fetal CAP and the placental interactions
might modulate the neuroimmune mechanisms employed to
mitigate the CSS, possibly reducing tissue and cell damages, and
potentially minimizing the effects of a SARS-CoV-2 infection
(Kreis et al., 2020). Interestingly, recent studies have proposed
that some severe COVID-19 manifestations could be linked to an
impairment of the CAP (Farsalinos et al., 2020). Some authors
even consider that the administration of a cholinergic agonist
(e.g., pyridostigmine) could inhibit the inflammatory response
and lower the mortality of COVID-19 patients (Ahmed, 2020). A
disruption of the CAP may thus cause or exacerbate the severity
of the maternal and fetal CSS. Interestingly, some preclinical
evidence shows that a decreased fetal neuroinflammation is
correlated with higher vagus nerve activity fluctuations in near-
term ovine fetuses (Frasch et al., 2016).
The CAP may be more relevant in a SARS-2-CoV infection
compared with other physiological mechanisms because further
evidence indicates that the vagus nerve plays a relevant role in
pulmonary inflammation (dos Santos et al., 2011). A detailed
description of the neuroimmune mechanisms related to a
possible CAP and its impairment in the case of this infection
can be found elsewhere (Leitzke et al., 2020; Liu W. et al.,
2020). In SARS-CoV-2 infections, young patients generally
experience mild symptoms, while fatal interstitial pneumonia
is more frequently reported in older patients. It is known that
vagal activity declines with normal aging (De Meersman and
Stein, 2007), and some authors have already suggested that a
deregulated CAP can be associated with the severemanifestations
of COVID-19 disease (Farsalinos et al., 2020). Thus, we speculate
that an attenuated maternal CAP could also lead to a worse
prognosis of COVID-19 in pregnant women and their offspring.
In pregnancy, preclinical studies support a presumed link
between cholinergic signaling in fetal brain microglia and
the inflammatory state, suggesting the possibility that early
disruptions in microglial iron metabolism may impair fetal
neurodevelopment (Cortes et al., 2017). Owing to the changing
nature of human development from childhood to adulthood,
and the participation of peripheral macrophages in the
synaptogenesis of brain’s microglia as well as innate immune
responses, other authors consider that the effects of a permanent
peripheral cholinergic activation can have an effect on the
programming of the brain wiring and immune function (Frasch
et al., 2018).
Additionally, other findings suggest that fetal CAP activity
via vagal nerve stimulation using agonists of the α7 subunit
of the nicotinic acetylcholine receptor (α7nAChR) abrogates
the activation of brain astrocytes and microglia, thereby
restoring their physiological immunometabolic phenotype and
thus preventing a sustained switch to a reactive phenotype with
decreasing glial priming (Frasch et al., 2019). We speculate that a
disrupted fetal or maternal CAP during COVID-19 disease may
thus contribute to fetal neuroinflammation, prenatal stress, and
even preterm labor.
A non-invasive psychophysiological approach to indirectly
evaluate the activity of the autonomic nervous system is the
analysis of HRV, which has been considered as an important
“window” for understanding the neuroimmune interactions
involving the vagus nerve (Huston and Tracey, 2011) and also the
response to inflammatory processes (Williams et al., 2019). Thus,
we propose the analysis of maternal and fetal HRV as a non-
invasive, economic, and quantitative approach to reliably assess
the maternal and fetal CAP and the potential MIA produced by
COVID-19 disease during human pregnancy.
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PERSPECTIVE
Given the possible effects on neurodevelopment that can affect
human development and the quality of life, the understanding
of the maternal and fetal vagal–immune pathway during a
gestational infection by SARS-CoV-2, and exploring the short-
and long-term psychophysiological condition of the offspring,
warrant special attention. This knowledge demands the use of
non-invasive and economic physiological measures to assess fetal
and maternal cardiac vagal activity, such as the maternal and
fetal HRV. In this context, the use of a vagal nerve stimulation
(VNS) for treating COVID-19 has also been proposed (Bonaz
et al., 2020; Fudim et al., 2020). By activating the vagus nerve, it
has been demonstrated positive therapeutic effects on COVID-19
symptoms via anti-inflammatory mechanisms (Mazloom, 2020).
Further preliminary observations suggest that VNS provides
clinical benefits in patients with this disease (Staats et al., 2020).
Our main perspective is that the continuous monitoring of
maternal and fetal vagal activity by HRV would also be an
innovative application for managing COVID-19 patients.
Currently, there is insufficient evidence of the relationship
among MIA, SARS-CoV-2, the CAP, and neurodevelopmental
disorders. Our manuscript aims to offer a brief perspective and
hypothesizes about a potential MIA by SARS-CoV-2, which
could lead to neurodevelopmental disorders. We have also
considered a cytokine cross-talk between the mother and the
fetus as well as the role of the CAP (Figure 1). We highlight
the urgent necessity of creating multicenter and international
databanks of maternal-fetal psychophysiological signals,
obtained pre-, during, and post-infection by SARS-CoV-2 from
pregnant women. Preclinical studies over long enough periods
should also be conducted, allowing these disorders to appear.
Other authors support the consideration that health indicators
of maternal, neonatal, and subsequent development should
be also monitored after in-utero exposure to SARS-CoV-2
(Easterlin et al., 2020). Furthermore, longitudinal recordings
and offspring neurodevelopmental assessments including
immunological markers are desirable to appraise long-term
effects. We anticipate that the collection of such multivariate data
will help to understand the neuroimmune mechanisms activated
by the SARS-CoV-2 infection from a translational perspective in
both pregnant women and offspring.
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